Accelerate Diagnostics, Inc.Accelerate Diagnostics, Inc.Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc.

No trades
See on Supercharts
Market capitalization
‪17.68 M‬USD
−5.5111USD
‪−61.62 M‬USD
‪12.06 M‬USD
‪12.94 M‬
Beta (1Y)
−0.11

About Accelerate Diagnostics, Inc.

CEO
Jack Phillips
Headquarters
Tucson
Employees (FY)
134
Founded
1982
ISIN
US00430H2013
FIGI
BBG000CDVK08
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AXDX is 0.7365 USD — it has decreased by 9.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Accelerate Diagnostics, Inc. stocks are traded under the ticker AXDX.
Accelerate Diagnostics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
AXDX stock is 16.42% volatile and has beta coefficient of −0.11. Check out the list of the most volatile stocks — is Accelerate Diagnostics, Inc. there?
One year price forecast for Accelerate Diagnostics, Inc. has a max estimate of 1.0000 USD and a min estimate of 1.0000 USD.
AXDX earnings for the last quarter are 0.18 USD whereas the estimation was −1.07 USD which accounts for 117.22% surprise. Estimated earnings for the next quarter are −0.75 USD. See more details about Accelerate Diagnostics, Inc. earnings.
Accelerate Diagnostics, Inc. revenue for the last quarter amounts to ‪3.30 M‬ USD despite the estimated figure of ‪3.53 M‬ USD. In the next quarter revenue is expected to reach ‪3.45 M‬ USD.
Yes, you can track Accelerate Diagnostics, Inc. financials in yearly and quarterly reports right on TradingView.
AXDX stock has fallen by 16.78% compared to the previous week, the month change is a 22.47% fall, over the last year Accelerate Diagnostics, Inc. has showed a 89.48% decrease.
No, AXDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AXDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Accelerate Diagnostics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
AXDX reached its all-time high on Jun 27, 2014 with the price of 318.5620 USD, and its all-time low was 0.8300 USD and was reached on Apr 4, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 134.00 employees. See our rating of the largest employees — is Accelerate Diagnostics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Accelerate Diagnostics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Accelerate Diagnostics, Inc. stock shows the sell signal. See more of Accelerate Diagnostics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Accelerate Diagnostics, Inc. future price: according to them, AXDX price has a max estimate of 1.00 USD and a min estimate of 1.00 USD. Read a more detailed Accelerate Diagnostics, Inc. forecast: see what analysts think of Accelerate Diagnostics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Accelerate Diagnostics, Inc. EBITDA is ‪−50.77 M‬ USD, and current EBITDA margin is −421.05%. See more stats in Accelerate Diagnostics, Inc. financial statements.